AffordableGLP-1Providers Take the quiz
Rankings · updated 2026-08-26

What the highest dose costs, program by program

Last verified 2026-08-26 · methodology · conflict-of-interest disclosure · dataset: open JSON

The month-one price is a starter-dose price; this table is the other end. 3 programs on file hold one price at every dose — their top-dose cost is their entry cost — while dose-tiered programs run to the top recorded tiers shown below (LillyDirect’s regular top tier reaches $699). Verified rows lead; “top recorded tier” means the highest figure on file, not necessarily the ceiling. Last verified 2026-08-26.
ProviderMedicationHighest-dose / moBasisStatus
NexLifetirzepatide$139flat — same as entryVerified
Mochi Healthtirzepatide$278top recorded tierVerified
Remedy Medssemaglutide$299flat — same as entryVerified
NovoCaresemaglutide$349flat — same as entryVerified
LillyDirecttirzepatide$699top recorded tierVerified
Rotirzepatide$699top recorded tierReported

Why this column decides year-one cost

Titration means most patients spend more months at higher doses than at the starter dose — so a $199 program that reaches $449 by maintenance costs more in year one than a flat $278 program, and the advertised price told you nothing. The flat-rate ranking is this page’s mirror; the provider scorecards carry each program’s dose policy and conditions verbatim.

Best for

  • Patients at or heading to maintenance doses — price the dose you’ll live at, not the one you start at

Not best for

  • Month-one shoppers — intro pricing is a different question, covered on the self-pay page

Unverified — listed, not ranked

115 additional programs in the dataset don’t yet have the field this ranking sorts on — they’re listed in the verification queue, not silently excluded and not silently included. Only first-party-verified rows can win a category; reported rows appear with their provenance.

Update log
  • 2026-08-26 — Page created from the live dataset per the Pass-12 audit; sortable columns added.